Sodium glucose transporter 2 inhibitor exposure and the risk of congenital malformations: nationwide birth cohort study
Jang M, Kim M, Suh HS
Nutr Metab Cardiovasc Dis. Pub. online 19 Jan 2026.
Leggi
Medial arterial calcification of the foot arteries is associated with incident cardiovascular events or all-cause mortality in patients with diabetes-related foot ulceration
Lan NSR, Hiew J, Chen P, et al.
Diabetes Res Clin Pract. Pub. online 15 Jan 2026.
Leggi
Socioeconomic and structural barriers to addressing obesity in communities: a scientific statement from the American Heart Association
Chung ST, Harrington J, Kandula NR, et al.
Circulation. Pub. online 15 Jan 2026.
Leggi
2025 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline for the primary care management of chronic kidney disease
Schwartz AR, Sosnov J, Brown J, et al.
Ann Intern Med. Pub. online 30 Dec 2025.
Leggi
Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes
Karakus KE, Chesshir L, Walker S, et al.
Diabetologia. Pub. online 15 Jan 2026.
Leggi
Weight regain after cessation of medication for weight management: systematic review and meta-analysis
West S, Scragg J, Aveyard P, et al.
BMJ. Pub. online 7 Jan 2026.
Leggi
FDA requests removal of suicidal behavior and ideation warning from glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications: FDA’s evaluation did not identify an increased risk of suicidal ideation or behavior with the use of GLP-1 RA medications
13 gennaio 2026
Leggi